Search Results 1201-1210 of 11396 for anti-TNF drugs

  1. A Study To Evaluate ELU001 In Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) - Mayo Clinic

    Prior treatment with folate receptor-targeting anti-cancer agent(s), or received investigational anti-cancer treatment ≤ 4 weeks, or within a time interval ...

  2. Safely dispose of unused medications this Take Back Day - Mayo Clinic News Network

    ROCHESTER, Minn. — Join Mayo Clinic and local law enforcement to safely and anonymously discard your unused and expired medications during National ...

  3. Cyclophosphamide, Ixazomib, And Dexamethasone In Treating Patients With Previously Untreated Symptomatic Multiple Myeloma - Mayo Clinic

    Drugs used in chemotherapy, such as cyclophosphamide and dexamethasone, work in different ways to stop the growth of cancer cells, either by killing the ...

  4. Hematology - Clinical trials

    Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...

  5. Clinical trials - Oncology (Medical)

    Testing The Addition Of An Anti-cancer Drug, Selinexor, To The Usual Chemotherapy Treatment (Temozolomide) For Brain Tumors That Have Returned After Previous ...

  6. Tirofiban (intravenous route) - Side effects & uses - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  7. Clinical trials - Oncology (Medical)

    ... treatment options compared to giving cabozantinib, nivolumab, or ipilimumab alone. Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual ...

  8. Isatuximab-irfc (intravenous route) - Side effects & uses - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  9. Fruquintinib (oral route) - Side effects & dosage - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  10. Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma - Mayo Clinic

    Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. Participation eligibility. Participant ...